Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Gem Aromatics's annualized net income for the quarter that ended in Jun. 2026 was ₹-315 Mil. Gem Aromatics's average Total Stockholders Equity over the quarter that ended in Jun. 2026 was ₹4,499 Mil. Therefore, Gem Aromatics's annualized ROE % for the quarter that ended in Jun. 2026 was -7.00%.
The historical rank and industry rank for Gem Aromatics's ROE % or its related term are showing as below:
NSE:GEMAROMA'
s ROE % Range Over the Past 10 Years
Min: -3.64 Med: 22.57 Max: 28.12
Current: -3.64
During the past 5 years, Gem Aromatics's highest ROE % was 28.12%. The lowest was -3.64%. And the median was 22.57%.
NSE:GEMAROMA's ROE % is ranked worse than 82.43% of 1588
companies
in the Chemicals industry
Industry Median: 6.285
vs NSE:GEMAROMA: -3.64
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Jun. 2026) net income data. The Revenue data used here is four times the quarterly (Jun. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Gem Aromatics ROE % Related Terms
Gem Aromatics ROE % Historical Data
* Premium members only.
The historical data trend for Gem Aromatics's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Gem Aromatics's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gem Aromatics ROE % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Gem Aromatics's ROE % distribution charts can be found below:
* The bar in red indicates where Gem Aromatics's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Gem Aromatics (NSE:GEMAROMA) has a ROE % of -7.00% as of Jun. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Gem Aromatics and its competitors. According to the industry distribution chart, Gem Aromatics ranks #1309 out of 1588 companies in the Chemicals industry, placing it in the top 82.4%.
Is Gem Aromatics' ROE % too high?
Gem Aromatics' current ROE % is -7.00%. Based on the distribution chart, Gem Aromatics ranks #1309 out of 1588 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Gem Aromatics has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Gem Aromatics' ROE % compare to DOW?
According to the Chemicals industry distribution chart, Gem Aromatics ranks #1309 out of 1588 companies for ROE %. This places Gem Aromatics in the lower half of its industry. The industry median ROE % is 6.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Chemicals company?
The median ROE % among Chemicals companies is 6.29, based on 1,588 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Gem Aromatics and its competitors. For the Chemicals industry, the median ROE % is 6.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gem Aromatics's current ROE % is -7.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gem Aromatics stock overvalued right now?
Gem Aromatics (NSE:GEMAROMA) has a current ROE % of -7.00%. The current ROE % is -7.00%. Gem Aromatics' overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Gem Aromatics (NSE:GEMAROMA), the current ROE % is -7.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gem Aromatics Ltd is an established manufacturer of specialty ingredients, including, essential oils, aroma chemicals and Value Added Derivatives in India. It offers a diversified portfolio of products, ranging from the Mother Ingredients to its various Value-Added Derivatives. Its products find application across a broad spectrum of industries, such as, oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness and pain management and personal care. The company offers approximately 70 products across its four product categories, namely, (i) mint and mint derivatives; (ii) clove and clove derivatives; (iii) phenol; and (iv) other synthetic and natural ingredients.
19GF Score
Get the complete analysis for NSE:GEMAROMA
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GEMAROMA has been successfully added to your 
